NYSE — Healthcare: Manufacturing, Medical Devices: Surgical & Medical Instruments & Apparatus
www.stryker.comThe patent US9421280 for the SPY AGENT GREEN KIT, assigned to Stryker Corp and NOVADAQ TECHNOLOGIES ULC, is set to expire on November 24, 2025. This patent covers a method for assessing the patency of donor organs through the use of a fluorescent dye, which helps ensure the viability of transplanted organs by observing the continuous fluorescent signals in the vessels. The expiration of this patent may allow for greater competition in the market, potentially impacting the financial positioning of the related companies.
Patent ExpirationPatent US8185176 for the SPY AGENT GREEN KIT, assigned to Stryker Corp and NOVADAQ TECHNOLOGIES ULC, is set to expire on June 4, 2028. This patent relates to methods and systems for neurovascular imaging, which impacts the technological landscape and competitive positioning in the medical imaging field. The expiry may open the market to generic competitors, potentially altering the financial dynamics and revenue streams for the companies involved.
Patent ExpiryPatent US8647605 for SPY AGENT GREEN KIT, assigned to Stryker Corp and NOVADAQ TECHNOLOGIES ULC, is set to expire on February 11, 2029. This patent covers methods and systems for imaging vessels, particularly in the context of solid organ transplants, which highlights its significance in medical procedures. The expiration of this patent may enable increased competition and broader use of such imaging technology, potentially impacting Stryker's market position and revenues.
Patent ExpirationPatent US8406860 for the SPY AGENT GREEN KIT, related to Stryker Corp and NOVADAQ TECHNOLOGIES ULC, is set to expire on April 9, 2029. This patent covers technology for assessing vessel perfusion and myocardial blush using fluorescence imaging, which is critical for evaluating cardiac function. The expiration of this patent may allow for increased competition in the market for related medical imaging products, potentially impacting Stryker Corp's business operations and financial performance.
Patent ExpirationThe patent for SPY AGENT GREEN KIT, a product developed by Stryker Corp and NOVADAQ TECHNOLOGIES ULC that involves measuring changes in blood volume in a tissue using fluorescence agents, is set to expire on August 4, 2035. This expiration could impact the product's market exclusivity, potentially allowing for increased competition in the medical technology sector. The patent covers methods and apparatus that ensure accurate measurements of blood flow, a significant aspect for applications in medical diagnostics.
Patent ExpiryThe patent US11712320 for the SPY AGENT GREEN KIT, assigned to Stryker Corp and NOVADAQ TECHNOLOGIES ULC, is set to expire on July 14, 2039. This patent covers a surgical system that enhances video images of surgical sites, which is crucial for improving surgical visibility and precision. The expiration of this patent may open the door for competitors to develop similar technologies, potentially impacting Stryker's market position in the surgical imaging sector.
Patent Expiration